BioCorRx Inc. (BICX)
BICX is quoted over the counter, not listed on an exchange. BioCorRx Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | BICX, quoted over the counter |
| SEC CIK | 0001443863 |
| OTC Markets tier | OTCID (price source, 2026-11-13) |
| SEC industry code | Services-Specialty Outpatient Facilities, NEC |
| Business address | Anaheim, CA |
| Incorporated in | NEVADA |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions raise substantial doubt about the Company's ability to continue as a going concern for the next twelve-month period since the date of the financial statements were issued." | 10-Q 2026-08-14 |
| Cash and burn | $21K cash; operating cash flow -$589K a quarter. | Report 2026-06-30 |
| Shares outstanding | 29,758,177 (2026-08-14); 23,685,343 a year earlier; 8,524,910 three years earlier. | Cover page 2026-08-14 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | M&K CPAS, PLLC, The Woodlands, Texas, United States | PCAOB Form AP 2026-03-31 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $88K | -$965K | -$440K | $21K | $1.3M | $787K | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $215K | -$831K | -$433K | $212K | $1.2M | $877K | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | -$151K | $553K | -$848K | $139K | $1.2M | $797K | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $635K | -$1.9M | -$634K | $288K | $70K | $948K | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $178K | -$1.2M | -$126K | $112K | $1.5M | $313K | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $135K | -$841K | -$690K | $24K | $1.5M | $139K | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $0 | -$1.2M | -$247K | $88K | $71K | $8K | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $0 | -$1.5M | -$358K | $90 | $1.3M | $27K | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2019-02-14 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-09-04 |
Source: SEC EDGAR submissions feed, 500 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier